Thrombin does NOT cleave C5 under physiological conditions

A novel whole blood model revealed that thrombin does not cleave native C5.

Selected by the J Immunol Editor as “Top Read”.


Previous reductionist experiments using purified proteins have shown that thrombin cleaves C5. We modified our known whole blood model, which is based on lepirudin as anticoagulant (specifically inhibiting thrombin), and which has been used for 20 years as the most physiological relevant model to study inflammation in human whole blood in vitro. In this study, we replaced lepirudin by GPRP, a small protein that blocks coagulation one step below thrombin – GPRP blocks fibrin polymerization. Robust data using GPRP instead of lepirudin clearly show that thrombin cannot cleave native C5, but cleaves the conformationally changed C5, which occurs during e.g purification or low pH.

It is difficult to challenge old established truths, but when we finally succeeded after several years, the Editor in Journal of Immunology selected this as a “Top Read” paper in the September 15, 2021 Issue.

The main work has been performed by Per H. Nilsson and Tom E. Mollnes, the first and last authors, respectively.

Read the paper


Read the dissemination of this article in Norwegian newspapers and blogs Dagens Medisin
Scroll Up

Similar News

Sep 29. 2023.

NCRG visited European Congresses 2023

The 29th International Complement Workshop was arranged in Newcastle. Twelve Norwegian complementologists attended with all together 8 presentations affiliated with...

Read more

15th Aegean Conference on Complement Therapeutics

Beatrice Fageräng At the 15th Aegean Complement Conference in Chania, Crete, 26-31 May 2023 Beatrice Fageräng from the NCRG received...

Read more

6th NCRG Symposium at Kjerringøy

19 members of the NCRG joined the 6th Norwegian Complement Symposium at Kjerringøy. Kjerringøy is an old traditional trading place ...

Read more